§ 25-822

D.C. Code § 25-822

Mandatory revocation.

Effective Mar 22, 2023Jan. 24, 1934, 48 Stat. 330, ch. 4, § 17; Aug. 27, 1935, 49 Stat. 900, ch. 756, § 9; Aug. 25, 1937, 50 Stat. 803, ch. 766, § 3; Apr. 26, 1950, 64 Stat. 88, ch. 106; Dec. 8, 1970, 84 Stat. 1393, Pub. L. 91-535, § 3(a); Sept. 29, 1982, D.C. Law 4-157, §§ 9, 15, 29 DCR 3617; Mar. 8, 1984, D.C. Law 5-51, § 2(b)(5), 30 DCR 5927; Mar. 7, 1987, D.C. Law 6-217, § 11, 34 DCR 907; Sept. 11, 1993, D.C. Law 10-12, § 2(b), 40 DCR 4020; May 24, 1994, D.C. Law 10-122, § 2(h), 41 DCR 1658; Apr. 30, 1998, D.C. Law 12-97, § 2, 45 DCR 1517; May 3, 2001, D.C. Law 13-298, § 101, 48 DCR 2959; Apr. 11, 2019, D.C. Law 22-288, § 201(b); June 30, 2022, D.C. Law 24-127, § 2(g)(2); Mar. 22, 2023, D.C. Law 24-332, § 5

  1. (a) The Board shall revoke the license of a licensee as a result of any of the following events during the period for which the license was issued:

    1. (1) The licensee has been convicted of multiple violations of the terms of this title or the regulations issued under this title and the penalties set forth in Chapter 8 or established by the Board require revocation;
    2. (2) The licensee has knowingly permitted, in the licensed establishment (A) the illegal sale, or negotiations for sale, or the use, of any controlled substance identified in the CSA, or (B) the possession, other than for personal use, or sale, or negotiations for sale, of drug paraphernalia in violation of the CSA or Chapter 11 of Title 48. Successive sales, or negotiations for sale, over a continuous period of time shall be deemed evidence of knowing permission;
    3. (3) The licensee has been convicted of a felony; or
    4. (4) The licensee has been convicted of assaulting an ABCA investigator or a member of the Metropolitan Police Department during the commission of an ABCA investigation.
  2. (b) For the purposes of this section, the term "personal use" means the possession of drug paraphernalia in circumstances where there is no evidence of an intent to distribute or manufacture a controlled substance.

History

Jan. 24, 1934, 48 Stat. 330, ch. 4, § 17

Aug. 27, 1935, 49 Stat. 900, ch. 756, § 9

Aug. 25, 1937, 50 Stat. 803, ch. 766, § 3

Apr. 26, 1950, 64 Stat. 88, ch. 106

Dec. 8, 1970, 84 Stat. 1393, Pub. L. 91-535, § 3(a)

Sept. 29, 1982, D.C. Law 4-157, §§ 9, 15, 29 DCR 3617

Mar. 8, 1984, D.C. Law 5-51, § 2(b)(5), 30 DCR 5927

Mar. 7, 1987, D.C. Law 6-217, § 11, 34 DCR 907

Sept. 11, 1993, D.C. Law 10-12, § 2(b), 40 DCR 4020

May 24, 1994, D.C. Law 10-122, § 2(h), 41 DCR 1658

Apr. 30, 1998, D.C. Law 12-97, § 2, 45 DCR 1517

May 3, 2001, D.C. Law 13-298, § 101, 48 DCR 2959

Apr. 11, 2019, D.C. Law 22-288, § 201(b)

June 30, 2022, D.C. Law 24-127, § 2(g)(2)

Mar. 22, 2023, D.C. Law 24-332, § 5

Prior Codifications

1973 Ed., § 25-118.

1981 Ed., § 25-822.

Emergency Legislation

For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see § 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497).

For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see § 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964).

Log InSign Up